Share on LinkedInShare on LinkedIn

ARTICLE · 14 SEPTEMBER 2023

Two More Companies Admit To Fixing Generic Drug Prices

According to the DOJ, these are the first resolutions in this litigation that require companies to divest their pravastatin-related products. Pravastatin is a widely used cholesterol treatment medicine.

United StatesAntitrust/Competition Law

Teva Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Inc., USA have agreed to the terms demanded by the Department of Justice to resolve price-fixing charges against the companies, a scheme that affected the prices of several critical generic drugs.

According to the DOJ, these are the first resolutions in this litigation that require companies to divest their pravastatin-related products. Pravastatin is a widely used cholesterol treatment medicine.

  • Israel-based Teva must pay $225 million in what DOJ says is the largest ever against a domestic antitrust cartel.
  • Teva also must donate $50 million in other drugs to people in need, drugs also affected by the scheme. These drugs are the antifungal clotrimazole (sold by Bayer under the brand name Lotrimin), and the antibiotic, tobramycin.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from